Global Intravitreal Injectable Competitive Landscape Professional Research Report 2024

Global Intravitreal Injectable Competitive Landscape Professional Research Report 2024

Research Summary

An intravitreal injectable is a medication administered directly into the vitreous cavity of the eye, which is the gel-like substance that fills the space between the lens and the retina. This injection is typically performed to deliver therapeutic agents for the treatment of various eye conditions, such as age-related macular degeneration, diabetic retinopathy, and macular edema. Common intravitreal injectables include anti-vascular endothelial growth factor (anti-VEGF) drugs, steroids, or other agents designed to address specific pathological processes within the eye. The injection is usually done in an outpatient setting, and the procedure helps to achieve a high concentration of the medication at the target site, minimizing systemic side effects. Intravitreal injectables have become a standard and effective approach in the management of retinal disorders, contributing to improved visual outcomes and preventing further progression of certain eye diseases.

According to DIResearch's in-depth investigation and research, the global Intravitreal Injectable market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Intravitreal Injectable include Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, Genentech, Kanghong Pharmaceutical etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Intravitreal Injectable. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Intravitreal Injectable market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Intravitreal Injectable market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Intravitreal Injectable industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.    

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Intravitreal Injectable Include:

Regeneron Pharmaceuticals (Eylea)

Allergan

EyePoint Pharmaceuticals

Genentech

Kanghong Pharmaceutical

Intravitreal Injectable Product Segment Include:

Anti-VEGF

Steroids

Others

Intravitreal Injectable Product Application Include:

Macular Degeneration

Macular Edema

Uveitis

Retinal Vein Occlusion

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Intravitreal Injectable Industry PESTEL Analysis

Chapter 3: Global Intravitreal Injectable Industry Porter’s Five Forces Analysis

Chapter 4: Global Intravitreal Injectable Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 5: Global Intravitreal Injectable Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Intravitreal Injectable Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Intravitreal Injectable Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Intravitreal Injectable Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Intravitreal Injectable Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Intravitreal Injectable Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Intravitreal Injectable Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Intravitreal Injectable Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources